参考文献/References:
[1] 中华人民共和国国家卫生健康委员会医政司.肥胖症中国诊疗指南(2024年版)[J].协和医学杂志,2025,16:90-108.
Department of Medical Administration NHCotPRoC.Chinese Guidelines for the Clinical Management of Obesity(2024 Edition)[J].Med J Peking Union Med Coll Hosp,2025,16:90-108.
[2]Reig M,Forner A,Rimola J,et al.BCLC strategy for prognosis prediction and treatment recommendation:The 2022 update[J].J Hepatol,2022,76:681-693.
[3]Jia G,Van Valkenburgh J,Chen AZ,et al.Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma[J].Wiley Interdiscip Rev Nanomed Nanobiotechnol,2022,14:e1749.
[4]中国医师协会介入医师分会临床诊疗指南专委会.中国肝细胞癌经动脉化疗栓塞(TACE)治疗临床实践指南(2023年版)[J].中华医学杂志,2023,103:2674-2694.
Clinical Practice Guideline Committee of Interventional Physician Branch,Chinese Medical Doctor Association.Chinese Clinical Practice Guideline for Transarterial Chemoembolization(TACE)in Hepatocellular Carcinoma(2023 Edition)[J].Natl Med J China,2023,103:2674-2694.
[5]陈 节,李杨鼎薪,王 勇,等.中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值对TACE序贯微波消融治疗肝细胞癌预后的预测价值[J].介入放射学杂志,2025,34:79-84.
Chen J,Li YD,Wang Y,et al.The clinical value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in predicting the prognosis of patients with HCC after receiving TACE with sequential microwave ablation[J].J Interv Radiol,2025,34:79-84.
[6]杨延杰,马靖嶔,颜志平.可视化微球研究进展[J].介入放射学杂志,2024,33:115-121.
Yang YJ,Ma JQ,Yan ZP.Research progress of visualized microspheres[J].J Interv Radiol,2024,33:115-121.
[7]Mikhail AS,Negussie AH,Mauda-Havakuk M,et al.Drug-eluting embolic microspheres:state-of-the-art and emerging clinical applications[J].Expert Opin Drug Deliv,2021,18:383-398.
[8]Aliberti C,Carandina R,Sarti D,et al.Transarterial chemoembolization with DC Bead LUMITM radiopaque beads for primary liver cancer treatment:preliminary experience[J].Future Oncol,2017,13:2243-2252.
[9]Li J,Wang J,Li J,et al.Fabrication of Fe3O4@PVA microspheres by one-step electrospray for magnetic resonance imaging during transcatheter arterial embolization[J].Acta Biomater,2021,131:532-543.
[10]Wang H,Qin XY,Li ZY,et al.Preparation and evaluation of MRI detectable poly(acrylic acid)microspheres loaded with superparamagnetic iron oxide nanoparticles for transcatheter arterial embolization[J].Int J Pharm,2016,511:831-839.
[11]Yang Y,Yang R,Zhang B,et al.Preparation and investigation of a novel iodine-based visible polyvinyl alcohol embolization material[J].J Interv Med,2022,5:72-78.
[12]王文焕.X光显影碘代聚乳酸介入栓塞材料合成与性能[D].大连:大连理工大学,2019.
Wang WH.Synthesis and properties of X-ray radiopaque iodinatedpoly(lactic acid)interventional embolization materials[D].Dalian:Dalian University of Technology,2019.
[13]Wang Q,Qian K,Liu S,et al.X-ray visible and uniform alginate microspheres loaded with in situ synthesized BaSO4 nanoparticles for in vivo transcatheter arterial embolization[J].Biomacromolecules,2015,16:1240-1246.
[14]Yi Z,Sun Z,Shen Y,et al.The sodium hyaluronate microspheres fabricated by solution drying for transcatheter arterial embolization[J].J Mater Chem B,2022,10:4105-4114.
[15]Zeng J,Li L,Zhang H,et al.Radiopaque and uniform alginate microspheres loaded with tantalum nanoparticles for real-time imaging during transcatheter arterial embolization[J].Theranostics,2018,8:4591-4600.
[16]Deng XQ,Zhang HB,Wang GF,et al.Colon-specific microspheres loaded with puerarin reduce tumorigenesis and metastasis in colitis-associated colorectal cancer[J].Int J Pharm,2019,570:118644.
[17]Isaac EI,Hall J,Dault JB,et al.Transarterial chemoembolization with lc bead lumi followed by stereotactic body radiation therapy in treatment of hepatocellular carcinoma[J].Adv Radiat Oncol,2022,7:100830.
[18]Ruff C,Artzner C,Syha R,et al.Transarterial chemoembolization of hepatocellular carcinoma using radiopaque drug-eluting embolics:impact of embolic density and residual tumor perfusion on tumor recurrence and survival[J].Cardiovasc Intervent Radiol,2021,44:1403-1413.
[19]Reicher J,Mafeld S,Priona G,et al.Early experience of trans-arterial chemo-embolisation for hepatocellular carcinoma with a novel radiopaque bead[J].Cardiovasc Intervent Radiol,2019,42:1563-1570.
[20]Lakhoo J,Adams R,Dave A,et al.Radiopaque beads loaded with doxorubicin in the treatment of patients with hepatocellular carcinoma:a retrospective,multi-center study[J].Cancer Treat Res Commun,2020,25:100208.
[21]Sekhoacha M,Riet K,Motloung P,et al.Prostate cancer review:genetics,diagnosis,treatment options,and alternative approaches[J].Molecules,2022,27:5730.
[22]Han T,Yang X,Zhang Y,et al.The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma:a meta-analysis[J].Biosci Trends,2019,13:374-381.
[23]Li D,Pang Y,Xu L,et al.Efficacy and safety of sorafenib combined with TACE in the treatment of advanced hepatocellular carcinoma:a meta-analysis[J].J BUON,2021,26:1355-1364.
[24]Lakhoo J,Adams R,Dave A,et al.Radiopaque beads loaded with doxorubicin in the treatment of patients with hepatocellular carcinoma:a retrospective,multi-center study[J].Cancer Treat Res Commun,2020,25:100208.
[25]Biondetti P,Lanza C,Carriero S,et al.Efficacy and safety of transarterial chemoembolization with dc beads lumi in the treatment of hcc:experience from a tertiary centre[J].Technol Cancer Res Treat,2023,22:15330338231184840.
(收稿日期:2025-01-14)
(本文编辑:新 宇)
相似文献/References:
[1]曹海利,孟巍,白彬.肝癌基因治疗研究新进展[J].介入放射学杂志,2008,(05):375.
CAO Haili,MENG Wei,BAI Bin.New progress in research of gene therapy for hepatocellular carcinoma[J].J Intervent Med,2008,(03):375.
[2]陆骊工,胡宝山,李勇,等.中晚期原发性肝癌合并症的介入治疗研究[J].介入放射学杂志,2008,(07):514.
LU Ligong,HU Baoshan,LI Yong,et al.Study of interventional therapy for complications in advanced primary hepatocellular carcinoma[J].J Intervent Med,2008,(03):514.
[3]杨伟洪,刘鹏程,梁珊瑚,等.多层螺旋CT血管造影在判断肝癌寄生供血中的价值[J].介入放射学杂志,2008,(09):654.
YANG Weihong,LIU Pengchen g,LIANG Shanhu,et al.Evaluation of MSCTA for parasitic blood supply in hepatic carcinoma[J].J Intervent Med,2008,(03):654.
[4]张茵,周兵,许秀芳,等.肝动脉化疗栓塞治疗原发性肝癌存活２０年一例[J].介入放射学杂志,2008,(09):684.
ZHANG Yin,ZHOU Bing,XU Xiufang,et al.Survival more than２０years after transarterial chemical embolization for hepatocellular carcinoma：A case report[J].J Intervent Med,2008,(03):684.
[5]官泳松,贺庆.肝癌介入治疗中应用p５３的几个要点[J].介入放射学杂志,2008,(11):761.
GUAN Yongsong,HE Qing.Essentials in clinical application of p５３for tumors intervention－example of liver cancer[J].J Intervent Med,2008,(03):761.
[6]肖运平,肖恩华.介入治疗在防治肝癌术后复发中的作用及进展[J].介入放射学杂志,2008,(11):831.
XIAO Yunping,XIAO Enhua.The role and progress of interventional therapy in the prevention and treatment of postoperative hepatocellular carcinoma recurrence[J].J Intervent Med,2008,(03):831.
[7]史震山,陈自谦,杨熙章,等.原发性大肝癌患者TACE后S－腺苷蛋氨酸的护肝作用[J].介入放射学杂志,2008,(11):790.
SHI Zhenshan,CHEN Ziqian,YANG Xizhang,et al.The clinical study on the liver－protection of S－adenosy－methionine in large hepatocellular carcinoma patients after TACE[J].J Intervent Med,2008,(03):790.
[8]王耀普,杨康健,赵思源,等.兔肝癌模型的改良接种及其DSA影像分析[J].介入放射学杂志,2010,(03):214.
WANG Yaopu,YANG Kangjian,ZHAO Siyuan,et al.The modified inoculation method for the preparation of rabbit VX２hepatic carcinoma model and DSA imagining observation[J].J Intervent Med,2010,(03):214.
[9]贺洪德,贺晶,罗中华,等.肝动脉化疗栓塞联合门静脉栓塞治疗中晚期肝癌的疗效评价[J].介入放射学杂志,2010,(03):191.
HE Hongde,HE Jing,LUO Zhonghua,et al.Evaluation of the therapeutic effect of hepatic arterial chemoembolization combined with portal chemoembolization for advanced hepatic carcinomas[J].J Intervent Med,2010,(03):191.
[10]李广琪,曹玮,李超,等.肝动脉热灌注对兔肝VX２肿瘤及正常肝组织血管渗透性功能的作用[J].介入放射学杂志,2010,(03):217.
LI Guangqi,CAO Wei,LI Chao,et al.Influence of hepatic artery thermotherapy on the vascular permeability of hepatic tumor tissue and normal liver tissue in VX２tumor－bearing rabbits[J].J Intervent Med,2010,(03):217.